Corcept Therapeutics: Pay

Corcept Therapeutics paid its 5 named executives $40.4M in total in FY2025 (Dec). CEO Joseph K. Belanoff, M.D. was paid $15.3M of that.

Pay$100 in the stock at the end of FY20 → $133

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Joseph K. Belanoff, M.D.Chief Executive Officer and President


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)							Not disclosed
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Charles RobbChief Business Officer and Secretary


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

William Guyer, Pharm.D.Chief Development Officer


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Sean MaduckPresident Corcept Endocrinology


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Atabak MokariChief Financial Officer and Treasurer


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.